AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A good retirement plan is essential for financial security in your later years. Explore the key features that make a retirement plan effective.
19,612 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A former Google engineer turned $7.2 AI CEO says the hiring surge is real, but the toughest filter is drive and work ...
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
A landmark ruling would change who pays tariff costs and could lift earnings for U.S. companies. Markets react as inv...
Public interest in high-profile missing-person cases can fuel scams. This practical guide shows how to protect your m...
A new study finds family wealth, not just earnings, largely determines who becomes a homeowner. The findings come as ...
Delta and United just reported, but the big question remains: what's next airline stocks? This guide breaks down the ...
Primerica's earnings trajectory hinges on policy sales, investment product performance, and agent distribution. This ...
Vanguard's Dividend Appreciation ETF (VIG) yields about 1.5% today, but behind that modest payout lies a 20-year stre...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...
A Brookings study released this spring estimates ICE enforcement costs the economy about 668,000 jobs, unraveling the...
OpenAI has redefined its mission and governance, moving into a for-profit structure and removing safety language from...